FDA Inspection 923073 — Altaire Pharmaceuticals, Inc.

Altaire Pharmaceuticals, Inc. — FEI 1000119582

The FDA completed an inspection of Altaire Pharmaceuticals, Inc. on April 13, 2015 in Aquebogue, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 13, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Aquebogue, NY (United States)